Method for the treatment of an autoimmune disease with an agent comprising CTRP3
Abstract:
Provided is an agent for the treatment of an autoimmune disease, the agent comprising C1q/TNF-related protein 3 (CTRP3), and a method for the treatment of an autoimmune disease, the method comprising: administering an agent, which comprises CTRPb3 for the treatment of an autoimmune disease, to a subject in need of a treatment of an autoimmune disease.
Public/Granted literature
Information query
Patent Agency Ranking
0/0